RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH PULMONARY-EMBOLISM - CORRELATION OF FIBRINOLYTIC SPECIFICITY AND EFFICACY

被引：35

作者：

VAUGHAN, DE

GOLDHABER, SZ

KIM, J

LOSCALZO, J

机构：

[1] BRIGHAM & WOMENS HOSP,DEPT MED,DIV VASC MED & CARDIOL,75 FRANCIS ST,BOSTON,MA 02115

[2] BETH ISRAEL HOSP,DIV CARDIOL,BOSTON,MA 02215

[3] HARVARD UNIV,SCH MED,BOSTON,MA 02115

来源：

CIRCULATION | 1987年 / 75卷 / 06期

关键词：

D O I：

10.1161/01.CIR.75.6.1200

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1200 / 1203

页数：4

共 13 条

[1]

A National Cooperative Study, 1973, CIRCULATION S2, V47, pII1

[2] ANTIBODY-DIRECTED UROKINASE - A SPECIFIC FIBRINOLYTIC AGENT [J].

BODE, C ;

MATSUEDA, GR ;

HUI, KY ;

HABER, E .

SCIENCE, 1985, 229 (4715) :765-767

[3] RELATION OF EFFECTIVENESS OF INTRACORONARY THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION TO SYSTEMIC THROMBOLYTIC STATE [J].

BURKET, MW ;

SMITH, MR ;

WALSH, TE ;

BREWSTER, PS ;

FRAKER, TD .

AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (07) :441-444

[4] ANALYSIS OF COAGULATION AND FIBRINOLYSIS DURING INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].

COLLEN, D ;

BOUNAMEAUX, H ;

DECOCK, F ;

LIJNEN, HR ;

VERSTRAETE, M .

CIRCULATION, 1986, 73 (03) :511-517

[5]

ELMS MJ, 1983, THROMB HAEMOSTASIS, V50, P591

[6] THE OCCURRENCE AND CLINICAL RELEVANCE OF FIBRIN FRAGMENTS IN BLOOD [J].

GAFFNEY, PJ .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1983, 408 (JUN) :407-423

[7]

GOLDHABER SZ, 1986, LANCET, V2, P886

[8]

MERSKEY C, 1966, BLOOD-J HEMATOL, V28, P1

[9] SULFITE PRECIPITATION METHOD FOR FIBRINOGEN MEASUREMENT - USE ON SMALL SAMPLES IN PRESENCE OF FIBRINOGEN DEGRADATION PRODUCTS [J].

RAMPLING, MW ;

GAFFNEY, PJ .

CLINICA CHIMICA ACTA, 1976, 67 (01) :43-52

[10]

SHARMA GVRK, 1982, NEW ENGL J MED, V306, P1268

← 1 2 →